



Non-tuberculous Mycobacterium (NTM) Infections and Heater-Cooler Devices 
Interim Practical Guidance:  Updated October 27, 2015 
Purpose:  
  CDC has identified a need for increased vigilance for NTM infections by health departments, 
healthcare facilities, and individual healthcare providers.  FDA recently issued a Safety Communication 
on Nontuberculous Mycobacterium Infections Associated with Heater-Cooler Devices that addresses 
issues regarding the proper use and maintenance of these devices.  CDC has been working with the FDA 
and local and state health departments to investigate heater-cooler units associated with NTM 
infections and/or found to be contaminated with NTM.  This CDC communication is to (a) raise 
awareness among health departments, healthcare facilities, and healthcare providers of the possible 
association between NTM infections and use of heater-cooler devices and (b) to provide guidance on 
identifying patients with infection.  
Summary: 
Heater-cooler devices are commonly used during cardiac surgical procedures to warm and cool 
a patient’s blood during cardiopulmonary bypass.  NTM are slow-growing bacteria that are found in 
surface water, tap water, and soil.  Recent reports have suggested an association between heater-cooler 
devices and NTM infections among patients undergoing cardiac surgery potentially through the 
aerosolization of bacteria from contaminated water used in these devices.1,2,3,4,5 
The most important action to protect patients will be to remove contaminated heater-coolers 
from operating rooms, and ensure that those in service are correctly maintained.6 
Patients who might have been exposed to NTM during a surgical procedure should continue to 
look for signs of potential infection and keep in touch with their clinicians for further evaluation. Due to 
the potentially long delay between exposure to NTM and manifestation of clinical infection (up to 
several years), identifying infections related to the use of heater-cooler devices can be challenging.    
Recommendations for health departments: 
• Local and state health departments should communicate with healthcare facilities that perform 
cardiac surgical procedures, or facilities that may provide care to patients who have undergone 
such procedures, to ensure that the devices have been assessed, their maintenance reviewed 
and any potentially contaminated devices are removed from service.  Clinical staff should be 
alerted to maintain increased awareness in identifying NTM infections potentially associated 
with surgery that uses heater-cooler devices.   
• Health departments should track reports from healthcare facilities regarding potential infections 
associated with heater-cooler units, encourage facilities to report these events to FDA, and be 
prepared to assist healthcare facilities with further investigation as needed.  CDC is available to 






Recommendations for healthcare facilities: 
Healthcare facilities should immediately assess their use of heater-cooler units and ensure that they are 
safe and properly maintained.  In addition, clinical staff should maintain heightened vigilance for 
possible NTM infections among patients who have undergone cardiac surgical procedures that involved 
the use of heater-cooler devices.  Some actions that healthcare facilities should consider include: 
• Ensure that your facility is following the most current manufacturer’s instructions and following 
FDA’s recommendations for maintenance, cleaning, disinfection and monitoring of heater-
cooler devices 
• If a heater-cooler device in your facility tests positive for NTM or if there is concern for patient 
infections related to the heater-cooler device, review your facility’s microbiology laboratory 
database and records of surgical procedures to identify any patients that have had NTM-positive 
cultures within four years following a cardiac surgery procedure. 
• If a heater-cooler device is suspected to have led to patient infections or if a heater-cooler 
device has tested positive for NTM, promptly notify your local health department, submit a 
report to FDA via MedWatch, and assess the  need for notifying exposed patients in 
coordination with public health authorities.  
Recommendations for healthcare providers: 
Healthcare providers should have increased suspicion for NTM infections among patients who have 
signs of infection and a history of cardiac surgery.  When seeing patients, actions that providers should 
consider include: 
• Assessment for NTM infection for patients who report signs or symptoms of infection and who 
have undergone cardiac surgery within the previous four years.  
• Patients suspected to have an NTM infection should also be assessed for a history of cardiac 
surgery or exposure to a heater-cooler device.  Note that other healthcare exposures such as 
injections, plastic surgery, and dialysis may also be associated with NTM infections and warrant 
consultation with public health authorities or reporting to FDA.  
• Order mycobacterial culture in patients who have undergone a cardiac procedure within the 
previous four years who present with signs of infection. 
• Patients with NTM infections following cardiac surgery have presented with a variety of 
clinical manifestations.  Common examples include endocarditis, surgical site infection, 
or abscess and bacteremia.  Other clinical manifestations have included hepatitis, renal 
insufficiency, splenomegaly, pancytopenia, and osteomyelitis.  
• Diagnosis can be difficult due to the non-specific presentation of illness, but it is 
important that providers maintain an index of suspicion in patients with a history of 
cardiac surgery. Consider arranging consultation with an infectious disease specialist.  It 
is also important to obtain acid fast bacteria (AFB) cultures from an infected wound 
and/or blood to increase the likelihood of identification of the organism as well as to 





Recommendations for patients: 
Patients who have recently had cardiac surgery should contact their health care provider if they 
have (a) symptoms of NTM infection, which may include a combination of the following: fever; 
pain, redness, heat, or pus around a surgical incision; night sweats; joint pain; muscle pain; 
weight loss; and fatigue; as well as failure to thrive in infants; or (b) questions about possible or 
exposure to a heater-cooler device.   
 
Those who were exposed to NTM should continue to look for signs of unexplained infection and 
keep in touch with their clinicians for further evaluation and tracking. 
 
Posted by:   CDC’s Division of Healthcare Quality Promotion 
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